Cleveland Clinic CEO Toby Cosgrove announces plans to step down - cleveland.com

cleveland.com

Cleveland Clinic CEO Toby Cosgrove announces plans to step down cleveland.com Cleveland Clinic CEO Toby Cosgrove announced Monday that he would step down as head of the company later this year. (Marvin Fong/The Plain Dealer). Print Email · Kris Wernowsky, cleveland.com By Kris Wernowsky, cleveland.com The Plain Dealer Toby Cosgrove steps down as Cleveland Clinic President, CEOfox8.com Toby Cosgrove will step down as CEO of Cleveland ClinicCrain's Cleveland Business all 5 news articles »

from Health - Google News http://ift.tt/2qvlsyE

A generation of heroin orphans - CNN

A generation of heroin orphans CNN (CNN) It was bedtime in the Flynn household but the kids were wide awake, excited by the arrival of CNN reporters to their colorful, crowded Kentucky home. The entry is crammed with bunk beds on one side and, separated by a bookshelf, a makeshift den ... and more »

from Health - Google News http://ift.tt/2qvIpBS

Toby Cosgrove steps down as Cleveland Clinic President, CEO - fox8.com

fox8.com

Toby Cosgrove steps down as Cleveland Clinic President, CEO fox8.com CLEVELAND– Cleveland Clinic President and Chief Executive Officer Dr. Toby Cosgrove will step down from his position. Cosgrove, who spent 13 years as president and CEO, made the announcement to transition out of the position at a staff meeting ... and more »

from Health - Google News http://ift.tt/2qoPS6m

A Lazarus Patient And The Limits Of A Lifesaving Stroke Procedure - NPR

NPR

A Lazarus Patient And The Limits Of A Lifesaving Stroke Procedure NPR On July 17, 2014 Kurt Hinrichs, of Gladstone, Mo., went to bed early. As often happens, he woke in the middle of the night. When he tried to get out of bed, he crashed to the floor, which woke his wife, Alice. "At first it was like, 'What's going on ... and more »

from Health - Google News http://ift.tt/2p0CSTn

Neurotrope Alzheimer's drug data fails to impress; shares plunge - Reuters

STAT

Neurotrope Alzheimer's drug data fails to impress; shares plunge Reuters Neurotrope Inc said on Monday the smaller dose of its experimental Alzheimer's drug met the main goal in a small mid-stage study, but shares tumbled 36 percent in premarket trading as investors were not impressed with the data. In the Neurotrope trial ... Neurotrope misses primary endpoint in Alzheimer's trialFierceBiotech In small Alzheimer's study, hints of modest benefit from unusual drugSTAT all 9 news articles »

from Health - Google News http://ift.tt/2pmZsYX